Table 3.
Multivariable regression impact of different variables on the duration of P&R negotiation (days)
P&R negotiation (days) | Coefficient | Standard error | p value | 95% CI |
---|---|---|---|---|
Added therapeutic value > 3a | −79.6 | 36.3 | 0.023 | −3.6 to −155.6 |
Managed entry agreement (yes) | 140.8 | 68.9 | 0.048 | 5.8–275.8 |
Baseline | 138.9 | 48.3 | 0.010 | 37.9–239.9 |
P&R price and reimbursement, CI confidence interval
aThe added therapeutic value is published only for indications subject to innovativeness appraisal, thus limiting the number of observations (n = 24)